Rishabh Instruments Ltd

AI

Rishabh Instruments Ltd

₹ 610 4.77%
20 Nov - close price
About

Rishabh Instruments limited, with an experience of nearly three decades is an organization that has built its core competence in manufacturing, design and development of Test and Measuring Instruments and Industrial Control Products on strong fundamentals; in terms of people, infrastructure and financials. The company provides a hands-on, value driven, professional environment considering people its most important asset.[1]

Key Points

Business Overview:[1]
RIL manufactures, designs and develops industrial control products (ICPs), including transducers, analogue and digital panel meters, and electronic testing and measurement instruments such as hand-held multimeters and digital and analogue insulation testers. Through its subsidiary, it also manufactures aluminium high-pressure die-cast components.

  • Market Cap ₹ 2,369 Cr.
  • Current Price ₹ 610
  • High / Low ₹ 852 / 315
  • Stock P/E 53.2
  • Book Value ₹ 125
  • Dividend Yield 0.33 %
  • ROCE 13.0 %
  • ROE 9.60 %
  • Face Value ₹ 10.0

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 25.3% CAGR over last 5 years

Cons

  • Stock is trading at 4.90 times its book value
  • Company has a low return on equity of 8.62% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
63 46 59 53 59 59 68 62 66 61 79 78 88
48 40 47 47 50 53 54 48 49 48 63 60 68
Operating Profit 15 5 12 6 9 6 14 14 17 13 16 18 20
OPM % 23% 12% 21% 12% 15% 10% 20% 23% 26% 21% 20% 23% 23%
1 1 3 2 3 3 2 3 4 3 3 3 3
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 2 2 4 3 3 4 4 4 4 5 5 4 5
Profit before tax 13 4 11 6 9 5 12 13 17 11 15 16 18
Tax % 25% -121% 63% 33% 22% 26% 24% 26% 25% 24% 27% 26% 25%
10 9 4 4 7 4 9 10 13 8 11 12 14
EPS in Rs 2.68 2.35 1.11 0.97 1.78 1.04 2.31 2.57 3.29 2.19 2.79 3.07 3.50
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
137 127 152 196 225 239 268 305
116 104 132 164 178 204 207 239
Operating Profit 21 23 20 32 46 36 61 67
OPM % 16% 18% 13% 16% 21% 15% 23% 22%
5 4 4 5 6 10 13 12
Interest 2 1 2 3 1 1 1 0
Depreciation 7 7 8 10 10 13 18 18
Profit before tax 17 19 14 24 41 31 56 60
Tax % 27% 29% 28% 23% 21% 26% 25%
12 14 10 19 32 23 42 45
EPS in Rs 3.44 3.72 2.84 5.15 8.48 6.09 10.81 11.55
Dividend Payout % 0% 0% 0% 0% 0% 0% 18%
Compounded Sales Growth
10 Years: %
5 Years: 16%
3 Years: 11%
TTM: 20%
Compounded Profit Growth
10 Years: %
5 Years: 25%
3 Years: 31%
TTM: 26%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 7%
1 Year: 45%
Return on Equity
10 Years: %
5 Years: 8%
3 Years: 9%
Last Year: 10%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Equity Capital 15 15 15 29 38 38 39 39
Reserves 185 192 202 214 333 371 421 443
42 21 28 22 6 1 3 3
25 31 36 40 35 40 43 56
Total Liabilities 267 258 281 305 411 450 506 541
32 39 42 41 41 59 62 95
CWIP 1 0 0 0 2 12 44 22
Investments 80 80 81 88 108 92 95 100
154 140 158 175 261 287 306 324
Total Assets 267 258 281 305 411 450 506 541

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
21 20 -1 -3 34 37 58
-25 4 -3 13 -76 -33 -68
12 -31 5 -9 57 -2 1
Net Cash Flow 8 -7 1 2 16 2 -9
Free Cash Flow 14 10 -10 -14 26 -3 8
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 120% 99% 28% 15% 87% 130% 119%

Ratios

Standalone / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 60 70 49 69 49 49 53
Inventory Days 209 241 279 262 297 239 236
Days Payable 73 110 107 93 67 66 73
Cash Conversion Cycle 195 202 221 238 279 222 215
Working Capital Days 85 99 93 140 157 169 136
ROCE % 9% 7% 11% 13% 8% 13%

Insights

In beta
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Total Capacity Utilization
% p.a.

Log in to view insights

Please log in to see hidden values.

Login
Actual Production
million units
Installed Capacity
million units p.a.
Asia Revenue Share
% of consolidated revenue
EEI Segment Revenue Share
% of consolidated revenue
Europe Revenue Share
% of consolidated revenue
R&D Centers
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

7 Recently
Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
70.68% 70.25% 70.16% 70.16% 70.16% 70.15% 69.81% 69.81% 69.67% 69.55% 69.40% 69.28%
2.10% 0.31% 0.11% 0.12% 0.11% 0.17% 0.05% 0.35% 0.24% 0.10% 1.17% 2.32%
14.71% 14.52% 13.34% 13.20% 13.45% 13.09% 12.42% 12.01% 12.57% 11.72% 11.21% 7.39%
0.00% 0.05% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
12.51% 14.87% 16.41% 16.53% 16.29% 16.59% 17.70% 17.83% 17.52% 18.63% 18.21% 21.02%
No. of Shareholders 35,85535,47839,60642,22342,03441,05640,23535,76533,80532,23130,70731,550

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Annual reports

Concalls